Overview

Analgesic Additives to Epidural Bupivacaine in Normal Labor

Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The aim of the study will be to compare the role of Dexmedetomidine, Nalbuphine and fentanyl as additives to epidural bupivacaine in painless vaginal delivery as regard of effectiveness analgesia and maternal safety.
Phase:
N/A
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine
Fentanyl
Nalbuphine